Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
Authors
Keywords
-
Journal
mAbs
Volume 6, Issue 5, Pages 1300-1313
Publisher
Informa UK Limited
Online
2014-08-05
DOI
10.4161/mabs.32106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity
- (2014) H. E. Kohrt et al. BLOOD
- B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies
- (2014) K Bojarczuk et al. LEUKEMIA
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib
- (2012) Nicole Hassold et al. INTERNATIONAL JOURNAL OF CANCER
- Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
- (2012) Magdalena Winiarska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy
- (2012) L. Bologna et al. JOURNAL OF IMMUNOLOGY
- Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
- (2011) P. V. Beum et al. JOURNAL OF IMMUNOLOGY
- Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
- (2010) J. Bil et al. BLOOD
- Novel therapeutic agents for B-cell lymphoma: developing rational combinations
- (2010) C. B. Reeder et al. BLOOD
- Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts
- (2010) Ingo Ringshausen et al. CANCER RESEARCH
- In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling
- (2010) S. de Haij et al. CANCER RESEARCH
- Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth
- (2010) Jiyuan Ke et al. Molecular Cancer
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
- (2009) J. Hiraga et al. BLOOD
- Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
- (2009) M. G. Kharas et al. BLOOD
- Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma
- (2009) Y. Terui et al. CLINICAL CANCER RESEARCH
- Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX
- (2009) A. W. Pawluczkowycz et al. JOURNAL OF IMMUNOLOGY
- Dasatinib suppresses in vitro natural killer cell cytotoxicity
- (2008) S. J. Blake et al. BLOOD
- The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils
- (2008) M. Kneidinger et al. BLOOD
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- (2008) Akiko Miyagi Maeshima et al. CANCER SCIENCE
- Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo
- (2008) Cara K. Fraser et al. EXPERIMENTAL HEMATOLOGY
- Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib
- (2008) C Yang et al. LEUKEMIA
- Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients
- (2008) Aylin Sar et al. LEUKEMIA RESEARCH
- Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20
- (2008) Magdalena Winiarska et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now